Survival probabilities of patients with childhood spinal muscle atrophy

Mohannad M Mannaa1, Maninder Kalra, Brenda Wong

  • 1Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

Insights

Advances in pulmonary care and nutritional support have significantly improved survival rates for children with severe spinal muscular atrophy (SMA). This study highlights a positive trend in life expectancy for pediatric SMA patients over time.

Area of Science:

  • Pediatric Neurology
  • Medical Genetics
  • Clinical Outcomes Research

Background:

  • Medical and technological advancements have enhanced patient care for pediatric spinal muscular atrophy (SMA) over the last two decades.
  • Survival patterns in SMA patients have been a focus of research due to the disease's progressive nature.

Purpose of the Study:

  • To analyze changes in life expectancy for pediatric patients diagnosed with spinal muscular atrophy (SMA).
  • To compare current survival trends with previously documented patterns in SMA patient populations.

Main Methods:

  • Retrospective review of medical records for pediatric SMA patients from 1989 to 2005.
  • Data collection included diagnosis, interventions, pulmonary complications, and mortality.
  • Kaplan-Meier survival analysis was employed to assess survival probabilities.

Main Results:

  • A significant improvement in survival probabilities was observed in patients with the most severe form of spinal muscular atrophy (SMA).
  • The study identified a positive trend in survival rates for pediatric SMA patients during the study period.

Conclusions:

  • A notable positive trend in survival exists for patients with severe spinal muscular atrophy (SMA).
  • While multifactorial, improvements in pulmonary care and aggressive nutritional support are likely key contributors to enhanced survival.
  • Continued research into factors influencing SMA patient survival is warranted.
Abstract

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...